MedTrace Logo

Musculoskeletal Non-tumoral Pathology Quantitative Perfusion

NCT02683252 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2018-08-23

No results posted yet for this study

Summary

Study on quantitative perfusion parameters acquired on MR imaging of patients with non-tumoral pathology of the musculoskeletal system.

Conditions

  • Osteonecrosis
  • Pseudarthrosis
  • Compartment Syndrome

Interventions

OTHER

T1 mapping and MR perfusion acquisition

One T1 mapping acquisition with variable flip angles will be performed before contrast injection. One perfusion 3D FSPGR sequence will be acquired after contrast injection

Sponsors & Collaborators

  • University Hospital, Lille

    collaborator OTHER

  • Central Hospital, Nancy, France

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-12
Primary Completion
2019-02-12
Completion
2020-02-12

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02683252 on ClinicalTrials.gov